Trials / Completed
CompletedNCT00603876
Efficacy of Almonds Added to Chronic Statin Therapy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- University of Kansas · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the effects of 100-110 grams of almonds (about ¾ cupful) daily on the lipoprotein profile when given to patients on a statin drug. The study will compare the effects on the lipoprotein profile to patients who eat almonds and those patients not eating almonds.
Detailed description
The primary objectives of this study are to determine the changes in the lipid profile \[LDL-C, HDL-C, triglycerides, total cholesterol\], LDL-C particle size, and the emerging risk factor Lp(a) when 100-110 g of almonds daily are added to statin therapy. Also, all subjects will receive Step I dietary counseling.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Almonds | 100-110 grams (about 3/4 cupful)of almonds consumed daily for 28 days |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2008-01-29
- Last updated
- 2013-05-22
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00603876. Inclusion in this directory is not an endorsement.